| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77daaba4ed8a52f189334aef53bbffc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_391c839e90d82d68799545debff037bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1991a839e4723ca27e0014cf786bbab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
2008-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bacd747ec35d619ccc780d6af13c88b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e611df938661f60d02e6f45565afa6 |
| publicationDate |
2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0813011-B1 |
| titleOfInvention |
WATER INJECTABLE FORMULATION, PREPARATION PROCESS AND USE |
| abstract |
Sterile aqueous injectable formulation, process for preparing it and its use The invention relates to a sterile injectable aqueous gel formulation composed of hyaluronic acid (or one of its salts) with or without other polysaccharide (s) of natural origin and one or more polyols (s). This formulation is used intra-articular in the treatment of joint degeneration. in some cases it has a rheology close to that of synovial fluid and always has an increased resistance to degradation thanks to a synergistic effect between hyaluronic acid and polyols. |
| priorityDate |
2007-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |